Topical rapamycin for treating facial angiofibromas associated with tuberous sclerosis complex in people 6 years and over [ID6391]
In development
Reference number: GID-TA11455
Expected publication date: TBC
The company has informed NICE that it will not provide an evidence submission for this
appraisal. Therefore, we are suspending the appraisal while we consider the next steps